Cita APA

Vlahovic, G., Meadows, K. L., Hatch, A. J., Jia, J., Nixon, A. B., Uronis, H. E., . . . Hurwitz, H. I. (2018). A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist.

Chicago Style Citation

Vlahovic, Gordana, et al. "A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination With Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer." Oncologist 2018.

Cita MLA

Vlahovic, Gordana, et al. "A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination With Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer." Oncologist 2018.